Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial)

被引：0
|
作者：
Nelson, Axel
Shafazand, Amir
Cahlin, Christian
Carneiro, Ana
Helgadottir, Hildur
Levin, Max
Rizell, Magnus
Ullenhag, Gustav J.
Wiren, Sara
Lindner, Per
Nilsson, Jonas A.
Ny, Lars
Bagge, Roger Olofsson
机构：
[1] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Oncol,Inst Clin Sci, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Surg,Inst Clin Sci, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Transplant Inst,Inst Clin Sci, Gothenburg, Sweden
[4] Skane Univ Hosp, Ctr Comprehens Canc, Dept Hematol Oncol & Radiat Phys, Lund, Sweden
[5] Karolinska Univ Hosp, Stockholm, Sweden
[6] Univ Gothenburg, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden
[7] Uppsala Univ, Sect Oncol, Dept Immunol Genet & Pathol, Uppsala, Sweden
[8] Univ Hosp Umea, Dept Radiat Sci, Oncol, Umea, Sweden
[9] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Surg, Gothenburg, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
瑞典研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9533
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Overall Survival after Isolated Hepatic Perfusion in Combination with Ipilimumab and Nivolumab in Patients with Uveal Melanoma (SCANDIUM II trial)
    Nelson, Axel
    Shafazand, Amir
    Cahlin, Christian
    Carneiro, Ana
    Helgadottir, Hildur
    Levin, Max
    Rizell, Magnus
    Ullenhag, Gustav
    Wiren, Sara
    Lindner, Per
    Nilsson, Jonas A.
    Ny, Lars
    Bagge, Roger Olofsson
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [2] 72206-Overall Survival after Isolated Hepatic Perfusion in Combination with Ipilimumab and Nivolumab in Patients with Uveal Melanoma (SCANDIUM II trial)
    Nelson, Axel
    Shafazand, Amir
    Cahlin, Christian
    Carneiro, Ana
    Helgadottir, Hildur
    Levin, Max
    Rizell, Magnus
    Ullenhag, Gustav
    Wiren, Sara
    Lindner, Per
    Nilsson, Jonas A.
    Ny, Lars
    Bagge, Roger Olofsson
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [3] A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial).
    Bagge, Roger Olofsson
    Nelson, Axel
    Shafazand, Amir
    Cahlin, Christian
    Carneiro, Ana
    Helgadottir, Hildur
    Levin, Max
    Rizell, Magnus
    Ullenhag, Gustav J.
    Wiren, Sara
    Lindner, Per
    Nilsson, Jonas A.
    Ny, Lars
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] A phase Ib randomized multicenter trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab for uveal melanoma
    Bagge, R. Olofsson
    Nelson, A.
    Shafazand, A.
    Cahlin, C.
    Carneiro, A.
    Helgadottir, H.
    Levin, M.
    Rizell, M.
    Ullenhag, G.
    Wiren, S.
    Lindner, P.
    Nilsson, J. A.
    Ny, L.
    ESMO OPEN, 2024, 9 (07)
  • [5] Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)
    Nelson, Axel
    Shafazand, Amir
    All-Ericsson, Charlotta
    Cahlin, Christian
    Elander, Nils
    Helgadottir, Hildur
    Kiilgaard, Jens Folke
    Kinhult, Sara
    Ljuslinder, Ingrid
    Rizell, Magnus
    Eilard, Malin Sternby
    Ullenhag, Gustav
    Nilsson, Jonas A.
    Ny, Lars
    Lindner, Per
    Bagge, Roger Olofsson
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [6] Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)
    Nelson, Axel
    Shafazand, Amir
    All-Eriksson, Charlotta
    Cahlin, Christian
    Elander, Nils
    Helgadottir, Hildur
    Kiilgaard, Jens Folke
    Kinhult, Sara
    Ljuslinder, Ingrid
    Mattsson, Jan Erik
    Rizell, Magnus
    Eilard, Malin Sternby
    Ullenhag, Gustav J.
    Nilsson, Jonas A.
    Ny, Lars
    Lindner, Per
    Bagge, Roger Olofsson
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] 71691-Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)
    Nelson, Axel
    Shafazand, Amir
    All-Ericsson, Charlotta
    Cahlin, Christian
    Elander, Nils
    Helgadottir, Hildur
    Kiilgaard, Jens Folke
    Kinhult, Sara
    Ljuslinder, Ingrid
    Rizell, Magnus
    Eilard, Malin Sternby
    Ullenhag, Gustav
    Nilsson, Jonas A.
    Ny, Lars
    Lindner, Per
    Bagge, Roger Olofsson
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [8] Survival after isolated hepatic perfusion as a treatment for uveal melanoma liver metastases: Results from a randomized controlled trial (the SCANDIUM trial)
    Bagge, Roger Olofsson
    Nelson, Axel
    Shafazand, Amir
    All-Eriksson, Charlotta
    Cahlin, Christian
    Elander, Nils
    Helgadottir, Hildur
    Kiilgaard, Jens Folke
    Kinhult, Sara
    Ljuslinder, Ingrid
    Rizell, Magnus
    Eilard, Malin Sternby
    Ullenhag, Gustav J.
    Nilsson, Jonas A.
    Ny, Lars
    Lindner, Per
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
  • [9] Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
    Olofsson, Roger
    Ny, Lars
    Eilard, Malin Sternby
    Rizell, Magnus
    Cahlin, Christian
    Stierner, Ulrika
    Lonn, Ulf
    Hansson, Johan
    Ljuslinder, Ingrid
    Lundgren, Lotta
    Ullenhag, Gustav
    Kiilgaard, Jens Folke
    Nilsson, Jonas
    Lindner, Per
    TRIALS, 2014, 15
  • [10] Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial
    Roger Olofsson
    Lars Ny
    Malin Sternby Eilard
    Magnus Rizell
    Christian Cahlin
    Ulrika Stierner
    Ulf Lönn
    Johan Hansson
    Ingrid Ljuslinder
    Lotta Lundgren
    Gustav Ullenhag
    Jens Folke Kiilgaard
    Jonas Nilsson
    Per Lindnér
    Trials, 15
12345